Not applicableStudy completedNCT06342687What this trial is testingCompliance With ERAS and Five Year Survival After Colorectal Cancer TreatmentWho this might be right forColorectal CancerERAS Jagiellonian University 468
Early research (Phase 1)Ended earlyNCT03549000What this trial is testingA Phase I/Ib Study of NZV930 Alone and in Combination With PDR001 and /or NIR178 in Patients With Advanced Malignancies.Who this might be right forNon-small Cell Lung Cancer (NSCLC)Triple Negative Breast Cancer (TNBC)Pancreatic Ductal Adenocarcinoma (PDAC)+4 more Novartis Pharmaceuticals 127
Testing effectiveness (Phase 2)Looking for participantsNCT05786924What this trial is testingPhase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive MalignanciesWho this might be right forNon-small Cell Lung CancerHistiocytic NeoplasmHistiocytosis+29 more Institut de Recherches Internationales Servier 554
Early research (Phase 1)Looking for participantsNCT07229313What this trial is testingKIVU-107 in Participants With Locally Advanced or Metastatic Solid TumorsWho this might be right forAdvance Solid Tumors Kivu Bioscience Inc. 76
Testing effectiveness (Phase 2)Looking for participantsNCT05592626What this trial is testingA Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsGenital Neoplasm, FemaleUrogenital Neoplasms+11 more Marengo Therapeutics, Inc. 366
Testing effectiveness (Phase 2)WithdrawnNCT00936832What this trial is testingSunitinib Malate and Combination Chemotherapy as Front-Line Therapy in Treating Patients With Metastatic Rectal Cancer That Cannot Be Removed by SurgeryWho this might be right forColorectal CancerMetastatic Cancer Federation Francophone de Cancerologie Digestive
Testing effectiveness (Phase 2)Looking for participantsNCT07610798What this trial is testingEvaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D MutationsWho this might be right forAdvance Solid TumorsColon and Rectal CancerNon - Small Cell Lung Cancer NSCLC+4 more Shenzhen Ionova Life Sciences Co., Ltd. 178
Large-scale testing (Phase 3)Looking for participantsNCT06992648What this trial is testingTrifluridine/Tipiracil Plus Regorafenib vs Trifluridine/Tipiracil Plus Bevacizumab for Refractory Metastatic Colorectal CancerWho this might be right forColorectal Cancer MetastaticColorectal Cancer Recurrent Second Affiliated Hospital, Zhejiang University, School of Medicine 302
Early research (Phase 1)Study completedNCT03811652What this trial is testingA Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid TumorsWho this might be right forNon Small Cell Lung Cancer Squamous (NSCLC-Sq)Head and Neck Squamous Cell Carcinoma (HNSCC)Small Cell Lung Cancer (SCLC)+3 more MedImmune LLC 8
Early research (Phase 1)Study completedNCT02442414What this trial is testingKBP-5209 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Sihuan Pharmaceutical Holdings Group Ltd. 35
Large-scale testing (Phase 3)Study completedNCT03288987What this trial is testingComparing Efficacy and Safety of Stivant (AryoGen Bevacizumab) Versus Avastin in Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer AryoGen Pharmed Co. 126
Not applicableUnknownNCT01295463What this trial is testingStudy of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for CancerWho this might be right forCancer Institut Català d'Oncologia 96
Testing effectiveness (Phase 2)Looking for participantsNCT07020221What this trial is testingVS-7375 in Patients With KRAS G12D-Mutated Solid TumorsWho this might be right forPancreatic Ductal AdenocarcinomaNon Small Cell Lung CancerColorectal Cancer+2 more Verastem, Inc. 295
Not applicableActive Not RecruitingNCT01505400What this trial is testingIntegrated Molecular Profiling in Advanced Cancers TrialWho this might be right forBreast CancerNon-small Cell Lung CancerColorectal Cancer+7 more University Health Network, Toronto 3,026
Early research (Phase 1)Looking for participantsNCT06756035What this trial is testingCT-95 in Advanced Cancers Associated With Mesothelin ExpressionWho this might be right forMesothelin-Expressing TumorsEpithelial Ovarian CancerMalignant Pleural Mesothelioma, Advanced+8 more Context Therapeutics Inc. 70
Early research (Phase 1)Study completedNCT02740985What this trial is testingClinical Study of AZD4635 in Patients With Advanced Solid MalignanciesWho this might be right forAdvanced Solid MalignanciesNon-Small Cell Lung Cancer (NSCLC)Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC)+1 more AstraZeneca 313
Testing effectiveness (Phase 2)Active Not RecruitingNCT06792435What this trial is testingXNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.Who this might be right forPancreatic Adenocarcinoma MetastaticLung Cancer (NSCLC)Ovarian Cancer+4 more Astellas Pharma Global Development, Inc. 240
Not applicableLooking for participantsNCT05884723What this trial is testingPreoperative Ketogenic Diet for Reduction of Hepatic SteatosisWho this might be right forLiver SteatosesLiver Metastasis Colon CancerNAFLD Anton Skaro 124
Not applicableLooking for participantsNCT07035886What this trial is testingMonitor the Fruzaqla Treatment of Adults With Metastatic Colorectal Cancer (mCRC) in South KoreaWho this might be right forColorectal Cancer Takeda 600
Early research (Phase 1)UnknownNCT00986661What this trial is testingAssess PV-10 Chemoablation of Cancer of the LiverWho this might be right forCancer Metastatic to the LiverHepatocellular CarcinomaMetastatic Melanoma+7 more Provectus Biopharmaceuticals, Inc. 78